solli summit 2026

An opening welcome to solli Summit 2026, setting the scene and goals for the day.

A bold look at what’s coming next in pharma media, and what leaders must act on now, from one of media’s most influential voices.

Exploring why healthcare marketing’s biggest challenge is architectural rather than tactical, and how smarter orchestration can replace fragmented execution.

An honest, client-led discussion on standout HCP campaigns—what worked, what was learned, and the strategic decisions behind their success.

Session 1 – What is vibe coding, and what happens when 300 pharma media leaders try it together? This session explores how vibe coding built a product for the solli community in minutes, then invites the room to collaborate live and build the next version together.

Session 2 – From collective build to shared outcome – this session reveals the AI product shaped by attendee input, along with ideas generated by solli Summit participants vibe coding throughout the day.

A discussion on whether pharma media is losing the art of connection in the age of automation, and how reconnecting with lived experience and emotional context strengthens patient engagement.

A senior-leader panel examining how organizations are reshaping teams, decision-making, and partnerships to stay competitive in a rapidly evolving media landscape.

A future-facing view of healthcare marketing’s intelligence era – and the infrastructure required to power innovation, performance, and trust.

Examining the shift from a singular point of care to an interconnected network of engagement moments—and its implications for planning and budget allocation.

An inside look at why cultural moments are powerful growth drivers for pharma brands – and how to show up in ways that are timely, human, and culturally relevant.

From collective build to shared outcome—this session reveals the AI agent shaped by attendee input, highlighting its potential uses and the power of industry-wide collaboration to turn ideas into open innovation.

Examining the risks of bias in AI-powered media decisioning and the practical governance, transparency, and design principles needed to build trustworthy, responsible systems in pharma.

Discussing the push for greater transparency in healthcare media, addressing cost opacity, hidden value leakage, and what accountable pricing should look like in regulated markets.

Exploring the strategic imperatives reshaping pharma media planning, the forces driving shifts in channel investment and audience engagement, and how brands can prepare for the skills, structures, and technologies defining the next era.